150
Participants
Start Date
June 1, 2022
Primary Completion Date
December 30, 2025
Study Completion Date
June 1, 2026
Zanubrutinib
Zanubrutinib 80mg qd po, 6 consecutive weeks
Dexamethasone
Dexamethasone, iv, 40 mg/d, for 4 days (The 4-day course of dexamethasone was repeated in the case of lack of response by day 10)
Beijing Hospital
OTHER_GOV
Navy General Hospital, Beijing
OTHER
Beijing Aerospace General Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Beijing Tongren Hospital
OTHER
Peking University People's Hospital
OTHER